Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06546072
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-06
Brief Title:
Deep Learning With MRI-based Multimodal-data Fusion Enhanced Postoperative Risk Stratification of Breast Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Deep Learning With MRI-based Multimodal-data Fusion Enhanced Postoperative Risk Stratification of Breast Cancer
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Breast cancer poses a significant global health challenge especially among women with high rates of recurrence and distant spread despite early interventions The timely identification of metastasis risk and accurate prediction of treatment strategies are critical for improving prognosis However the complex heterogeneity of breast tumors presents challenges in precise prognosis prediction Therefore the development of innovative methods for tumor segmentation and prognosis assessment is essential
The research conducted is a multicenter study that enrolled 1199 non-metastatic breast cancer patients from four independent centers Our study leverages the advancements in artificial intelligence AI to address this challenge This study is the first successful application of MRI-based multimodal prediction system to precisely identify the risk of postoperative recurrence in breast cancer patients
The research conducted is a multicenter study that enrolled 1199 non-metastatic breast cancer patients from four independent centers Our study leverages the advancements in artificial intelligence AI to address this challenge This study is the first successful application of MRI-based multimodal prediction system to precisely identify the risk of postoperative recurrence in breast cancer patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None